You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for Neurocrine Biosciences, Inc. v. Lupin Limited (D. Del. 2021)

✉ Email this page to a colleague

« Back to Dashboard

Neurocrine Biosciences, Inc. v. Lupin Limited (D. Del. 2021)

Docket	⤷ Sign Up	Date Filed	2021-07-16
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To
Jury Demand	None	Referred To
Parties	LUPIN ATLANTIS HOLDINGS S.A.
Patents	10,065,952; 8,039,627; 8,357,697
Attorneys	Nathan Roger Hoeschen
Firms	Bayard, P.A.
Link to Docket	External link to docket

Small Molecule Drugs cited in Neurocrine Biosciences, Inc. v. Lupin Limited

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Neurocrine Biosciences, Inc. v. Lupin Limited (D. Del. 2021)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2021-07-16	1	Complaint	“the ’697 patent”), 10,065,952 (“the ’952 patent”), 10,844,058 (“the ’058 patent”), 10,851,103 (“the …civil action for patent infringement of U.S. Patent Nos. 8,039,627 (“the ’627 patent”), 8,357,697 (“the…the ’103 patent”), 10,851,104 (“the ’104 patent”), 10,857,137 (“the ’137 patent”), 10,857,148 (“the ’148…148 patent”), 10,874,648 (“the ’648 patent”), 10,906,902 (“the ’902 patent”), 10,906,903 (“the ’903 patent… patent”), 10,912,771 (“the ’771 patent”), 10,919,892 (“the ’892 patent”), 10,940,141 (“the ’141 patent	External link to document
2023-01-11	122	Notice of Service	Initial Infringement Contentions for U.S. Patent Nos. 8,039,627, 8,357,697 and 11,311,532 (Crystal Pharmaceutical…: 35:271 Patent Infringement 16 July 2021 1:21-cv-01042 835 Patent - Abbreviated…: Federal Question None Nature of Suit: 835 Patent - Abbreviated New Drug Application(ANDA) Jurisdiction	External link to document
2023-03-10	152	Notice of Service	Initial Non-Infringement Contentions for U.S. Patent Nos. 10,065,952; 10,844,058; 10,851,103; and 10,851,104…: 35:271 Patent Infringement 16 July 2021 1:21-cv-01042 835 Patent - Abbreviated…: Federal Question None Nature of Suit: 835 Patent - Abbreviated New Drug Application(ANDA) Jurisdiction	External link to document
2023-06-30	235	Notice of Service	Plaintiff's Infringement Contentions for U.S. Patent Nos. 8,039,627 and 8,357,697 (Zydus Pharmaceuticals (USA…: 35:271 Patent Infringement 16 July 2021 1:21-cv-01042 835 Patent - Abbreviated…: Federal Question None Nature of Suit: 835 Patent - Abbreviated New Drug Application(ANDA) Jurisdiction	External link to document
2023-07-07	236	Notice of Service	Final Noninfringement Contentions for U.S. Patent Nos. 8,039,627 and 8,357,697 and Zydus Pharmaceuticals …Limiteds Final Invalidity Contentions for U.S. Patent Nos. 8,039,627 and 8,357,697 filed by Zydus Lifesciences…: 35:271 Patent Infringement 16 July 2021 1:21-cv-01042 835 Patent - Abbreviated…: Federal Question None Nature of Suit: 835 Patent - Abbreviated New Drug Application(ANDA) Jurisdiction	External link to document
2023-08-01	244	Notice of Service	Dr. William C. Schinzer Regarding U.S. Patent Nos. 10,065,952, 10,844,058, and 10,851,103 on Invalidity….S. Patent Nos. 8,039,627 and 8,357,697 on Invalidity; (2) Dr. S. Craig Dyar Regarding U.S. Patent Nos…: 35:271 Patent Infringement 16 July 2021 1:21-cv-01042 835 Patent - Abbreviated…Invalidity; (4) Dr. David J. Greenblatt Regarding U.S. Patent Nos. 10,857,137, 11,040,029, 10,952,997, 10,940,141…: Federal Question None Nature of Suit: 835 Patent - Abbreviated New Drug Application(ANDA) Jurisdiction	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.